Raphamin is a drug developed as an antiviral.[1][2][3][4] It is manufactured by the Russian company Materia Medica.[5]
References
edit- ^ Petrova, N. V.; Emelyanova, A. G.; Tarasov, S. A.; Aparin, P. G.; Ledov, V. A. (September 2023). "Efficacy of Raphamin against Pneumococcal Infection: a Preclinical Study". Bulletin of Experimental Biology and Medicine. 175 (5): 649–652. doi:10.1007/s10517-023-05919-7. PMID 37861906. S2CID 264348443.
- ^ Khamitov, Rustem F.; Nikiforov, Vladimir V.; Zaytsev, Andrey A.; Tragira, Irina N. (15 January 2022). "Evaluation of the efficacy and safety of a complex antiviral drug based on antibodies in the treatment of adult patients with acute respiratory viral infection". Terapevticheskii Arkhiv. 94 (1): 83–93. doi:10.26442/00403660.2022.01.201345. PMID 36286922.
- ^ Petrova, N. V.; Emelyanova, A. G.; Tarasov, S. A.; Glubokova, е. а.; Каrtashova, N. P. (December 2022). "Antiviral Activity of Technologically Processed Antibodies to CD4 Receptor against Influenza Infection". Bulletin of Experimental Biology and Medicine. 174 (2): 250–253. doi:10.1007/s10517-023-05683-8. PMC 9812737. PMID 36600043.
- ^ Ganina, K. K.; Petrova, N. V.; Tarasov, S. A.; Epstein, O. I. (May 2023). "Combined Drug with Antibacterial Effect Supports the Normal Intestinal Microflora". Bulletin of Experimental Biology and Medicine. 175 (1): 37–40. doi:10.1007/s10517-023-05806-1. PMID 37338753. S2CID 259201686.
- ^ "Инструкция по применению препарата Рафамин". rafamin.ru. Retrieved 12 November 2023.
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |